Mortality associated with the use of non‐vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban

OBJECTIVE: This study assesses the mortality outcomes of non‐vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with venous thromboembolism (VTE) and atrial fibrillation (AF). METHODS: Medical records of cancer patients receiving NOACs for VTE or AF between January 1, 2011, and Dece...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu‐Sheng, Kuan, Feng‐Che, Chao, Tze‐Fan, Wu, Michael, Chen, Shao‐Wei, Chen, Mien‐Cheng, Chung, Chang‐Ming, Chu, Pao‐Hsien, Lip, Gregory Y. H., Wu, Victor Chien‐Chia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Researcher
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525135/
https://www.ncbi.nlm.nih.gov/pubmed/34464520
http://dx.doi.org/10.1002/cam4.4241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525135/
https://www.ncbi.nlm.nih.gov/pubmed/34464520
http://dx.doi.org/10.1002/cam4.4241

Ejemplares similares